ResearcherShanghai Medical College of Fudan UniversityActive in the last 2 years
Peng Wang
Matched on ORCID iD 0000-0003-1975-7989; OpenAlex author ID A5115592205. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 17
2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: 1 paper
Papers 3
- Digital subtraction angiography-guided pancreatic arterial infusion of GEMOX chemotherapy in advanced pancreatic adenocarcinoma: a phase II, open-label, random… Co-author DOI 10.1186/s12885-024-12695-8↗
- Oncolytic virotherapy against the tumor microenvironment and its potential in pancreatic cancer. Last author DOI 10.4103/jcrt.jcrt_91_21↗
- A novel systemic inflammation response index (SIRI) for predicting the survival of patients with pancreatic cancer after chemotherapy. Co-author DOI 10.1002/cncr.30057↗
Closest collaborators
The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yehua Shen · 2 shared papers, 2016–2024 · strength 0.26
- Paper Digital subtraction angiography-guided pancreatic arterial infusion of GEMOX chemotherapy in advanced pancreatic adenoc… DOI 10.1186/s12885-024-12695-8↗
- Paper A novel systemic inflammation response index (SIRI) for predicting the survival of patients with pancreatic cancer afte… DOI 10.1002/cncr.30057↗
- Zhen Chen · 2 shared papers, 2016–2024 · strength 0.26
- Paper Digital subtraction angiography-guided pancreatic arterial infusion of GEMOX chemotherapy in advanced pancreatic adenoc… DOI 10.1186/s12885-024-12695-8↗
- Paper A novel systemic inflammation response index (SIRI) for predicting the survival of patients with pancreatic cancer afte… DOI 10.1002/cncr.30057↗
- Yalei Zhang · 1 shared paper, 2022 · strength 0.20
- Ling Mei Qian · 1 shared paper, 2022 · strength 0.20
- Changjing Huang · 1 shared paper, 2024 · strength 0.20
- Yongqiang Hua · 1 shared paper, 2024 · strength 0.20
- Hao Chen · 1 shared paper, 2024 · strength 0.20
- Lanyun Feng · 1 shared paper, 2024 · strength 0.20
- Chien‐shan Cheng · 1 shared paper, 2024 · strength 0.20
- Zhiqiang Meng · 1 shared paper, 2024 · strength 0.20
- Shulin Yu · 1 shared paper, 2016 · strength 0.06
- Hao Chen · 1 shared paper, 2016 · strength 0.06
- Yawen Geng · 1 shared paper, 2016 · strength 0.06
- Liping Zhuang · 1 shared paper, 2016 · strength 0.06
- Zhiqiang Meng · 1 shared paper, 2016 · strength 0.06
- Qi Qi · 1 shared paper, 2016 · strength 0.06
- Luming Liu · 1 shared paper, 2016 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.